Comparative efficacy of liposomal FK 506 with FK 506 (tacrolimus) with and without anti-CD4/CD8 monoclonal antibodies

Transplantation Proceedings

Volumn 31, Issue 7, 1999, Pages 2754-

  Moffatt, S D ^a,b   McAlister, V ^a,b   Calne, R Y ^a,b   Metcalfe, S M ^a,b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

OKT 4; OKT 8; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSAGE FORM; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; INTRAPERITONEAL DRUG ADMINISTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; ANTIGENS, CD8; DRUG CARRIERS; DRUG THERAPY, COMBINATION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; LIPOSOMES; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; TACROLIMUS;

EID: 0344718653     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(99)00553-9     Document Type: Conference Paper

References (4)

1. Pichlmayr R., Winkler M., Neuheus P., et al. Transplant Proc. 29:1997;2499.
2. Mayer A.D., Dmitrewski J., Squifflet J.P., et al. Transplantation. 64:1997;436.
3. Ko S., Nakajima Y., Kanehiro H., et al. Transplantation. 59:1995;1384.
4. Chen Z. Transplantation. 52:1991;1099.